172 related articles for article (PubMed ID: 8888739)
21. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management.
Morimoto A; Nakazawa Y; Ishii E
Pediatr Int; 2016 Sep; 58(9):817-25. PubMed ID: 27289085
[TBL] [Abstract][Full Text] [Related]
22. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives.
Sullivan KE; Delaat CA; Douglas SD; Filipovich AH
Pediatr Res; 1998 Oct; 44(4):465-8. PubMed ID: 9773832
[TBL] [Abstract][Full Text] [Related]
23. Hemophagoctic lymphohistiocytosis--recent concept.
Bhattacharyya M; Ghosh MK
J Assoc Physicians India; 2008 Jun; 56():453-7. PubMed ID: 18822626
[TBL] [Abstract][Full Text] [Related]
24. Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis.
de Saint Basile G; Fischer A
Curr Opin Rheumatol; 2003 Jul; 15(4):436-45. PubMed ID: 12819472
[TBL] [Abstract][Full Text] [Related]
25. Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B-cell depletion and therapeutic results.
Imashuku S; Obayashi M; Hosoi G; Sako M; Chen J; Mugishima H; Tsunamoto K; Hibi S; Todo S
Br J Haematol; 2000 Mar; 108(3):505-10. PubMed ID: 10759706
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies.
Seo JJ
Blood Res; 2015 Sep; 50(3):131-9. PubMed ID: 26457279
[TBL] [Abstract][Full Text] [Related]
27. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives.
Verbsky JW; Grossman WJ
Ann Med; 2006; 38(1):20-31. PubMed ID: 16448985
[TBL] [Abstract][Full Text] [Related]
28. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
[TBL] [Abstract][Full Text] [Related]
29. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
Wang J; Liu Z; Jiang LP; An YF; Zhao XD
Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
[TBL] [Abstract][Full Text] [Related]
30. Clinical aspects, immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis.
Lee WI; Chen SH; Hung IJ; Yang CP; Jaing TH; Chen CJ; Li SP; Huang JL
Pediatr Infect Dis J; 2009 Jan; 28(1):30-4. PubMed ID: 19057461
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
32. Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis.
Imashuku S; Hyakuna N; Funabiki T; Ikuta K; Sako M; Iwai A; Fukushima T; Kataoka S; Yabe M; Muramatsu K; Kohdera U; Nakadate H; Kitazawa K; Toyoda Y; Ishii E
Cancer; 2002 Jun; 94(11):3023-31. PubMed ID: 12115393
[TBL] [Abstract][Full Text] [Related]
33. [Secondary hemophagocytic syndromes].
Buda P; Gietka P; Wieteska-Klimczak A; Ksiazyk J
Wiad Lek; 2013; 66(2 Pt 2):153-63. PubMed ID: 25775810
[TBL] [Abstract][Full Text] [Related]
34. Impaired culture generated cytotoxicity with preservation of spontaneous natural killer-cell activity in cartilage-hair hypoplasia.
Pierce GF; Brovall C; Schacter BZ; Polmar SH
J Clin Invest; 1983 Jun; 71(6):1737-43. PubMed ID: 6223049
[TBL] [Abstract][Full Text] [Related]
35. Hemophagocytic syndromes.
Janka GE
Blood Rev; 2007 Sep; 21(5):245-53. PubMed ID: 17590250
[TBL] [Abstract][Full Text] [Related]
36. Familial hemophagocytic lymphohistiocytosis: too little cell death can seriously damage your health.
Fadeel B; Orrenius S; Henter JI
Leuk Lymphoma; 2001 Jun; 42(1-2):13-20. PubMed ID: 11699200
[TBL] [Abstract][Full Text] [Related]
37. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
38. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society.
Aricò M; Janka G; Fischer A; Henter JI; Blanche S; Elinder G; Martinetti M; Rusca MP
Leukemia; 1996 Feb; 10(2):197-203. PubMed ID: 8637226
[TBL] [Abstract][Full Text] [Related]
39. Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8.
Grossman WJ; Radhi M; Schauer D; Gerday E; Grose C; Goldman FD
Blood; 2005 Aug; 106(4):1203-6. PubMed ID: 15840696
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis.
Chung HJ; Park CJ; Lim JH; Jang S; Chi HS; Im HJ; Seo JJ
Int J Lab Hematol; 2010 Apr; 32(2):239-47. PubMed ID: 19614711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
